June 30, 2020
LEO Pharma strengthens global leadership team
BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma, a global leader in medical dermatology, today announced that Dr. Monica Shaw, M.D., and Nathalie Joannes…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
June 30, 2020
Vertex expands deal with NHS England to Include Kaftrio Kalydeco combo
As Vertex expands deal with NHS England to include Kaftrio in combination with Kalydeco, the cysitc fibrosis patients in England will be among the first in Europe to benefit from access to Kaftrio, if the medicine is approved by the European Commission.
June 30, 2020
Stevanato Group ends 2019 with double-digit growth and revenues of €570M
Italy-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, continued its growth in 2019, recording a positive trend on key financial indicators, with consolidated revenues of €570.3 million, an increase of +10.9% compared to 2018.
June 30, 2020
Mereo BioPharma strengthens its management team
Mereo BioPharma has named several new positions this week, thus reaffirming it’s management team with those appointments.
June 30, 2020
Biocorp in distribution deal for Mallya Technology with Roche Diabetes Care France
Roche Diabetes Care France, a healthcare company specializing in diabetes, will distribute Mallya to pharmacies in France to pharmacists and will integrate it into its Roche Diabetes digital ecosystem.
June 29, 2020
Arya Sciences Acquisition Corp. Shareholders Approve Business Combination Transaction with Immatics
Arya and Immatics’s previouslly announced business combination into combined company called Immatics N.V., has been approved by both companies’ shareholders,…
June 29, 2020
Seattle Genetics’s testing tisotumab vedotin in recurrent or metastatic cervical cancer (updated)
Seattle Genetics’ results from the phase 2 of trial testing tisotumab vedotin to treat patients with relapsed or progressed metastatic cervical cancer, showed clinically meaningful and durable objective responses with a manageable safety profile.
June 29, 2020
Rocket Pharmaceuticals gets FDA clearance for its gene therapy for Infantile Malignant Osteopetrosis
Rocket Pharmaceuticals has received clearance from the U.S. Food and Drug Administration (FDA) for the Company’s Investigational New Drug (IND) application for RP-L401, its, lentiviral vector (LVV)-based gene therapy for the treatment of Infantile Malignant Osteopetrosis (IMO), a rare, severe monogenic bone resorption disorder.
June 29, 2020
Adalvo waiting EC’s marketing authorization for Livogiva
Pharmaceutical company Adalvo today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for Livogiva, indicated for use in postmenopausal women with osteoporosis who are at high risk of having bone fractures.
June 29, 2020
Centogene to work with Lufthansa and Fraport in COVID-19 testing at the Frankfurt airport
Centogene has partnered exclusively with Lufthansa and with Fraport, the operator of Frankfurt Airport, to offer COVID-19 testing to passengers flying to and from Frankfurt Airport (FRA).